30 results
424B5
PRLD
Prelude Therapeutics Inc
19 May 23
Prospectus supplement for primary offering
4:09pm
or long-term, investment-grade, interest-bearing securities.
S-12
DIVIDEND POLICY
We have never declared or paid any cash dividends on our capital … organizations;
broker-dealers and traders in securities;
U.S. expatriates and certain former citizens or long-term residents of the United States;
Non-U.S
8-K
EX-1.1
yepyl4 zm4a9wsrm02u
19 May 23
Prelude Therapeutics Announces Launch of Proposed Public Offering
4:06pm
424B5
50fdbw 7chktucr
17 May 23
Prospectus supplement for primary offering
4:26pm
10-K
gu9dku jfkvh7ey4
16 Mar 21
Annual report
8:20am
424B4
ytud90bsy3ajf
7 Jan 21
Prospectus supplement with pricing info
4:11pm
DRS
najn9bk p6zmnlt
21 Dec 20
Draft registration statement
12:00am